New Gut-Targeted drug offers hope for cancer patients struggling with opioid side effects
NCT ID NCT07231796
Summary
This study examines how well a medication called naldemedine works for cancer patients who experience constipation as a side effect of opioid pain medication. Researchers will follow 100 adult cancer patients in the Netherlands who are already using laxatives but still have significant constipation. The goal is to measure improvements in bowel function and gather feedback on patients' experiences and satisfaction with this newer treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.